Log in to save to my catalogue

Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation

Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2833998792

Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation

About this item

Full title

Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation

Publisher

England: BMJ Publishing Group Ltd and British Cardiovascular Society

Journal title

Heart (British Cardiac Society), 2023-11, Vol.109 (22), p.1706-1713

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and British Cardiovascular Society

More information

Scope and Contents

Contents

ObjectiveAfter transcatheter aortic valve implantation (TAVI), the optimal regimen of anticoagulant therapy in patients with an additional indication for oral anticoagulation remains a matter of debate. This study investigates the efficacy of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) in patients after TAVI in a real-wor...

Alternative Titles

Full title

Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2833998792

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2833998792

Other Identifiers

ISSN

1355-6037

E-ISSN

1468-201X

DOI

10.1136/heartjnl-2023-322548

How to access this item